HoFH Treatment | EVKEEZA® (evinacumab-dgnb)
EVKEEZA is an injectable prescription medicine used along with other low-density lipoprotein (LDL) lowering medicines in people 5 years of age and older with a type of high cholesterol …
Evinacumab - Wikipedia
Evinacumab, sold under the brand name Evkeeza, is a monoclonal antibody medication for the treatment of homozygous familial hypercholesterolemia (HoFH). [4] [5] [6] Common side …
Evkeeza: Uses, Dosage, Side Effects - Drugs.com
2024年2月25日 · Evkeeza (evinacumab) belongs to a class of medications called angiopoietin-like protein 3 (ANGPTL3) inhibitor monoclonal antibodies. Evkeeza injection is used with other …
HoFH Treatment | EVKEEZA® (evinacumab-dgnb) Injection
EVKEEZA is an angiopoietin-like 3 (ANGPTL3) inhibitor indicated as an adjunct to other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and …
EVKEEZA is indicated as an adjunct to other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and pediatric patients, aged 5 years and older, with …
FDA approves add-on therapy for patients with genetic form of ...
FDA has approved Evkeeza (evinacumab-dgnb) injection as an add-on treatment for patients aged 12 years and older with homozygous familial hypercholesterolemia (HoFH), a genetic …
Evkeeza - European Medicines Agency (EMA)
2021年4月23日 · Evkeeza is a medicine used together with low-fat diet and other medicines to reduce levels of cholesterol in the blood. It is used in adults, adolescents and children aged 6 …